Frederick Yorra
Tarzana, CANPI 1770504896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,099 and has fallen 97.7% since, to $25 in 2022.
Across 81 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$235
- Boehringer Ingelheim$215
- AstraZeneca$203
- Regeneron Healthcare Solutions, Inc.$89
- Genentech USA, Inc.$86
- Actelion Pharmaceuticals US, Inc.$84
- plus $547 from 14 others
What the payments were for
- Food & beverage$1,459100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $235 |
| Boehringer Ingelheim | 12 | $215 |
| AstraZeneca | 12 | $203 |
| Regeneron Healthcare Solutions, Inc. | 4 | $89 |
| Genentech USA, Inc. | 4 | $86 |
| Actelion Pharmaceuticals US, Inc. | 4 | $84 |
| Philips North America LLC | 4 | $62 |
| Advanced Respiratory, Inc | 3 | $61 |
| Mylan Specialty L.p. | 3 | $57 |
| Bayer | 3 | $49 |
| Insmed, Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 2 | $38 |
| Novartis | 2 | $38 |
| Pfizer | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $32 |
| Circassia Inc. | 2 | $29 |
| Boston Scientific | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $17 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.